Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels

Cardiovascular Research

Volumn 87, Issue 3, 2010, Pages 561-568

  Bonta, Peter I ^a   Matlung, Hanke L ^a   Vos, Mariska ^a   Peters, Stephan L M ^a   Pannekoek, Hans ^a   Bakker, Erik N T P ^a   De Vries, Carlie J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Macrophage; Nuclear receptor; Remodelling; Smooth muscle; Vasodilatation constriction

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; NUCLEAR RECEPTOR NUR77; COLLAGENASE 3; MATRIX METALLOPROTEINASE; MESSENGER RNA; MMP13 PROTEIN, MOUSE; MMP2 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE; NR4A1 PROTEIN, MOUSE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REPAIR; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD FLOW; BLOOD PRESSURE; CAROTID ARTERY DISEASE; DISEASE MODEL; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEMODYNAMICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TIME; VASOCONSTRICTION; VASODILATATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BLOOD PRESSURE; CAROTID ARTERIES; CAROTID ARTERY DISEASES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMODYNAMICS; MACROPHAGES; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MICE; MICE, TRANSGENIC; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; REGIONAL BLOOD FLOW; RNA, MESSENGER; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 77954783328     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq064     Document Type: Article

References (33)

1. Humphrey JD. Mechanisms of arterial remodeling in hypertension: coupled roles of wall shear and intramural stress. Hypertension 2008;52:195-200.
2. Korshunov VA, Schwartz SM, Berk BC. Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov's phenomenon. Arterioscler Thromb Vasc Biol 2007;27:1722-1728.
3. Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006;26:987-994.
4. Bakker EN, Matlung HL, Bonta P, de Vries CJ, van Rooijen N, Vanbavel E. Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc Res 2008;78:341-348.
5. de Vries CJ, van Achterberg TA, Horrevoets AJ, ten Cate JW, Pannekoek H. Differential display identification of 40 genes with altered expression in activated human smooth muscle cells. Local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes. J Biol Chem 2000;275:23939-23947.
6. Arkenbout EK, de Waard V, van Bragt M, van Achterberg TA, Grimbergen JM, Pichon B et al. Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 2002;106:1530-1535.
7. Bonta PI, van Tiel CM, Vos M, van Thienen JV, Ferreira V, Arkenbout EK et al. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macro-phages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol 2006;26:2288-2294.
8. Bonta PI, Pols TW, de Vries CJ. NR4A nuclear receptors in atherosclerosis and vein-graft disease. Trends Cardiovasc Med 2007;17:105-111.
9. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-839.
10. Philips A, Lesage S, Gingras R, Maira MH, Gauthier Y, Hugo P et al. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol 1997;17: 5946-5951.
11. Mix KS, Attur MG, Al-Mussawir H, Abramson SB, Brinckerhoff CE, Murphy EP. Transcriptional repression of matrix metalloproteinase gene expression by the orphan nuclear receptor NURR1 in cartilage. J Biol Chem 2007;282:9492-9504.
12. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG et al. A Nurr1/CoREST pathway in microglia astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 2009;137:47-59.
13. Li L, Miano JM, Mercer B, Olson EN. Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 1996;132:849-859.
14. Hilgers RH, Schiffers PM, Aartsen WM, Fazzi GE, Smits JF, De Mey JG. Tissue angiotensin-converting enzyme in imposed and physiological flow-related arterial remodeling in mice. Arterioscler Thromb Vasc Biol 2004;24:892-897.
15. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997;17:2238-2244.
16. Schiffers PM, Henrion D, Boulanger CM, Colucci-Guyon E, Langa-Vuves F, van Essen H et al. Altered flow-induced arterial remodeling in vimentin-deficient mice. Arterioscler Thromb Vasc Biol 2000;20:611-616.
17. Bakker EN, van der Meulen ET, Spaan JA, Vanbavel E. Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling. Am J Physiol Heart Circ Physiol 2000;278:H1233-H1240.
18. Koop EA, Gebbink MF, Sweeney TE, Mathy MJ, Heijnen HF, Spaan JA et al. Impaired flow-induced dilation in mesenteric resistance arteries from receptor protein tyrosine phosphatase-mu-deficient mice. Am J Physiol Heart Circ Physiol 2005;288: H1218-H1223.
19. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26.
20. Besnard S, Bakouche J, Lemaigre-Dubreuil Y, Mariani J, Tedgui A, Henrion D. Smooth muscle dysfunction in resistance arteries of the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circ Res 2002;90:820-825.
21. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogen-esis: the good, the bad, and the ugly. Circ Res 2002;90:251-262.
22. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316: 1371-1375. (Pubitemid 17079680)
23. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 2000;101:598-603.
24. Schoenhagen P, Vince DG, Ziada KM, Tsutsui H, Jeremias A, Crowe TD et al. Association of arterial expansion (expansive remodeling) of bifurcation lesions determined by intravascular ultrasonography with unstable clinical presentation. Am J Cardiol 2001; 88:785-787.
25. Yamashita A, Shoji K, Tsuruda T, Furukoji E, Takahashi M, Nishihira K et al. Medial and adventitial macrophages are associated with expansive atherosclerotic remodeling in rabbit femoral artery. Histol Histopathol 2008;23:127-136.
26. Korshunov VA, Berk BC. Strain-dependent vascular remodeling: the 'Glagov phenomenon' is genetically determined. Circulation 2004;110:220-226.
27. Nuki Y, Matsumoto MM, Tsang E, Young WL, van Rooijen N, Kurihara C et al. Roles of macrophages in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab 2009;29:495-503.
28. Yan ZQ, Hansson GK. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 2007;219:187-203.
29. Humphries A, Weller J, Klein D, Baler R, Carter DA. NGFI-B (Nurr77/Nr4a1) orphan nuclear receptor in rat pinealocytes: circadian expression involves an adrenergic-cyclic AMP mechanism. J Neurochem 2004;91:946-955.
30. Maxwell MA, Cleasby ME, Harding A, Stark A, Cooney GJ, Muscat GE. Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J Biol Chem 2005;280:12573-12584.
31. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994;75:181-189.
32. Diatchenko L, Romanov S, Malinina I, Clarke J, Tchivilev I, Li X et al. Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes. J Leukoc Biol 2005;78:1366-1377.
33. Harant H, Lindley IJ. Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB. Nucleic Acids Res 2004;32:5280-5290.